PMGC Holdings (ELAB) risk factors
Item 1A of every PMGC Holdings Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors90 risks50 new28 dropped33 reworded
PMGC transitioned from a skincare firm into a diversified holding company acquiring manufacturing, packaging, and biotech businesses. Operating cash burn significantly exceeds revenue, requiring heavy reliance on equity purchase facilities. Assets and subsidiary equity are pledged as collateral to Streeterville Capital under financing agreements. Frequent reverse stock splits reflect severe downward pressure on common stock and low liquidity.
Filed Mar 30, 2026 - FY2024 10-K risk factors68 risks
PMGC Holdings faces significant going-concern doubts after incurring net losses of $6,245,737 in 2024. The company transitioned from skincare to a biotechnology holding model, relying heavily on third-party licensing like the MOA Life Plus agreement for lead asset EL-22. Operations are constrained by having only two full-time employees and one part-time employee.
Filed Mar 28, 2025